Risk-Reducing Medications Can Cut Breast Cancer Death Rates
TUESDAY, Dec. 13, 2022 (HealthDay News) — Risk-reducing medication can reduce the risk for breast cancer death in addition to lowering the risk for invasive breast cancer, according to a study published online Dec. 1 in the Journal of Clinical Oncolo…
Learn MoreWhat’s Driving the Ongoing Adderall Shortage — and What Parents Can Do
TUESDAY, Dec. 13, 2022 (HealthDay News) — Shortages of the ADHD drug Adderall are expected to continue for months, forcing families to scramble for ways to deal with their children’s attention deficit hyperactivity disorder (ADHD).The shortage has ca…
Learn MoreNirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
MONDAY, Dec. 12, 2022 (HealthDay News) — Nirmatrelvir plus ritonavir reduces the risk for hospitalization or death after an outpatient diagnosis of COVID-19 among older adults, according to a study published online Dec. 13 in the Annals of Internal M…
Learn MoreAddition of Immunomodulators Cuts Vascular Inflammation in RA
MONDAY, Dec. 12, 2022 (HealthDay News) — For patients with rheumatoid arthritis (RA), the addition of a tumor necrosis factor (TNF) inhibitor (TNFi) or addition of sulfasalazine and hydroxychloroquine (triple therapy) to methotrexate results in clini…
Learn MoreFewer Buprenorphine Initiation Episodes Seen During Pandemic
FRIDAY, Dec. 9, 2022 (HealthDay News) — The number of active prescriptions for buprenorphine remained stable during the COVID-19 pandemic, with fewer new treatment episodes and fewer episodes ending, according to a study published online Dec. 6 in th…
Learn MoreViral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
FRIDAY, Dec. 9, 2022 (HealthDay News) — Patients with COVID-19 taking molnupiravir or nirmatrelvir-ritonavir rarely have viral rebound, and rebound is not associated with increased mortality risk, according to a study published online Dec. 6 in JAMA …
Learn MoreRecommendations Updated for Treatment, Prevention of HIV
FRIDAY, Dec. 9, 2022 (HealthDay News) — In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antir…
Learn MorePaxlovid Safe for Pregnant Patients With COVID-19
FRIDAY, Dec. 9, 2022 (HealthDay News) — Pregnant patients treated with nirmatrelvir and ritonavir (Paxlovid) for COVID-19 tolerate the treatment well, according to a study published online Nov. 29 in JAMA Network Open.William M. Garneau, M.D., from t…
Learn MorePaxlovid pronto no será gratuito para los estadounidenses
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — El antiviral Paxlovid ha evitado que las personas enfermen de gravedad y mueran por la COVID-19 desde que salió, sin ningún costo para ellas.Pero a mediados del próximo año, el gobierno de EE. UU. …
Learn MoreLa elección de fármaco podría ser importante para los pacientes con degeneración macular
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — Uno de los dos medicamentos más comunes usados para tratar la degeneración macular asociada con la edad (DMAE) parece ser mejor que el otro, sugiere un nuevo estudio de tamaño reducido.Entre 106 pa…
Learn More